Anne B. Criss

452 total citations
7 papers, 360 citations indexed

About

Anne B. Criss is a scholar working on Pharmacology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anne B. Criss has authored 7 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 2 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anne B. Criss's work include Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Cancer therapeutics and mechanisms (1 paper). Anne B. Criss is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Cancer therapeutics and mechanisms (1 paper). Anne B. Criss collaborates with scholars based in United States. Anne B. Criss's co-authors include Mary F. Paine, Paul B. Watkins, Kimberly L. Beavers, Susan N. Pusek, Wilbur Widmer, Brian F. Thomas, Sherri Brown, Jennifer Snyder, Beat Steiner and L Nannizzi and has published in prestigious journals such as American Journal of Clinical Nutrition, Biochemical Journal and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Anne B. Criss

7 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne B. Criss United States 7 199 132 71 66 47 7 360
Michael E. Fitzsimmons United States 10 180 0.9× 151 1.1× 125 1.8× 41 0.6× 70 1.5× 16 466
N. Christine Halmes United States 10 260 1.3× 91 0.7× 143 2.0× 37 0.6× 27 0.6× 12 600
Akira Touchi Japan 9 384 1.9× 147 1.1× 157 2.2× 43 0.7× 32 0.7× 31 590
Tomomi Iwakiri Japan 10 120 0.6× 100 0.8× 107 1.5× 66 1.0× 56 1.2× 24 384
Tomokazu Ohnuma Japan 13 212 1.1× 145 1.1× 317 4.5× 61 0.9× 29 0.6× 24 561
Matthew D. Moore United States 4 269 1.4× 129 1.0× 88 1.2× 24 0.4× 31 0.7× 12 504
Weiqiao Chen United States 6 366 1.8× 117 0.9× 121 1.7× 47 0.7× 20 0.4× 8 560
J A Hinson United States 12 383 1.9× 162 1.2× 123 1.7× 43 0.7× 19 0.4× 17 589
Mary K. Bruno United States 9 585 2.9× 212 1.6× 135 1.9× 32 0.5× 34 0.7× 12 743
Yasuhiro Masubuchi Japan 16 598 3.0× 242 1.8× 153 2.2× 81 1.2× 55 1.2× 29 902

Countries citing papers authored by Anne B. Criss

Since Specialization
Citations

This map shows the geographic impact of Anne B. Criss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne B. Criss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne B. Criss more than expected).

Fields of papers citing papers by Anne B. Criss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne B. Criss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne B. Criss. The network helps show where Anne B. Criss may publish in the future.

Co-authorship network of co-authors of Anne B. Criss

This figure shows the co-authorship network connecting the top 25 collaborators of Anne B. Criss. A scholar is included among the top collaborators of Anne B. Criss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne B. Criss. Anne B. Criss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Paine, Mary F., Wilbur Widmer, Susan N. Pusek, et al.. (2008). Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine. American Journal of Clinical Nutrition. 87(4). 863–871. 49 indexed citations
2.
Paine, Mary F., Wilbur Widmer, Susan N. Pusek, et al.. (2006). A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice–felodipine interaction. American Journal of Clinical Nutrition. 83(5). 1097–1105. 115 indexed citations
3.
Paine, Mary F., Anne B. Criss, & Paul B. Watkins. (2005). Two Major Grapefruit Juice Components Differ in Time to Onset of Intestinal CYP3A4 Inhibition. Journal of Pharmacology and Experimental Therapeutics. 312(3). 1151–1160. 76 indexed citations
4.
Paine, Mary F., Anne B. Criss, & Paul B. Watkins. (2004). TWO MAJOR GRAPEFRUIT JUICE COMPONENTS DIFFER IN INTESTINAL CYP3A4 INHIBITION KINETIC AND BINDING PROPERTIES. Drug Metabolism and Disposition. 32(10). 1146–1153. 81 indexed citations
5.
Schmiedlin‐Ren, Phyllissa, et al.. (2001). The furocoumarin 6',7'-dihydroxybergamottin (DHB) accelerates CYp3A4 degradation via the ubiquitin-proteasomal pathway.. Drug Metabolism Reviews. 33. 97. 6 indexed citations
6.
Parise, Leslie V., Beat Steiner, L Nannizzi, Anne B. Criss, & David R. Phillips. (1993). Evidence for novel binding sites on the platelet glycoprotein IIb and IIIa subunits and immobilized fibrinogen. Biochemical Journal. 289(2). 445–451. 24 indexed citations
7.
Meng, Y. Gloria, Anne B. Criss, & Katy E. Georgiadis. (1990). J chain deficiency in human IgM monoclonal antibodies produced by Epstein‐Barr virus‐transformed B lymphocytes. European Journal of Immunology. 20(11). 2505–2508. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026